Prevalence and risk factors of gastroesophageal reflux symptoms in a Chinese retiree cohort
BMC Gastroenterology volume 12, Article number: 161 (2012)
Data about prevalence of gastroesophageal reflux diseases (GERD) from Asian populations are still scarce. To provide additional data on prevalence of GERD and investigate its potential risk factors, we performed this cross-sectional study in the Taizhou Retiree Cohort.
After physical examination, the participants were asked whether they suffered with heartburn or acid regurgitation in the last 12 months by trained interviewers, and if yes, the severity and frequency of the symptoms were recorded. Odds ratios (ORs) with 95% confidence intervals (CIs) for the associations of obesity and other risk factors with GERD were derived from logistic regression models.
8831 retirees completed the questionnaire and physical examination. In total 150 (1.7%) reported the symptoms occurring at least once per week within the last 12 months before the interview. Compared with subjects without GERD, having a history of diabetes mellitus (OR 2.2, 95% CI 1.4-3.5), hypertension (OR 1.4, 95% CI 1.0-2.1), gastritis (OR 8.2, 95% CI 5.8-11.5), peptic ulcer (OR 3.3, 95% CI 1.8-6.1) and high triglyceride level (≥1.81mmol/L) (OR 2.0, 95% CI 1.2-3.4) were associated with a significantly increased risk of GERD. However, there was no significant association between body mass index, waist-to-hip ratio or waist alone, smoking, consumption of alcohol & tea, and the occurrence of reflux symptoms.
Compared with Western populations, the prevalence of GERD in this Chinese retiree cohort is low. A history of diabetes mellitus, hypertension, gastritis, peptic ulcer or hypertriglyceridaemia increases GERD risk in this population.
Gastroesophageal reflux disease (GERD) is a chronic disease that is associated with a range of troublesome symptoms, which can in turn have a significant impact on health-related quality of life. Western countries have experienced GERD epidemic in recent decades; a systematic review article concluded that the prevalence of GERD was 10-20% in Western countries . Recently, the prevalence of GERD has been reported to increase rapidly in Asia [2–5]. However, studies on Asian populations are still scarce.
There is a widespread notion that obesity and abdominal obesity may increase the risk of GERD, especially in Western populations [6–9]. High body mass index (BMI) is associated with a dose-dependently increased risk for GERD, erosive esophagitis, and esophageal adenocarcinoma. Several studies have reported that the adverse effect of obesity on GERD is through mechanical alterations at the esophagogastric junction [10, 11]. However, since not every obese patient develops GERD, the pathogenesis must be multifactorial and cannot be explained by a single physiological parameter. Additional observations demonstrated the association between GERD and metabolic risk factors including hypertension, hypertriglyceridaemia and diabetes mellitus [12–14]. There is also suggestive relationship between GERD and peptic ulcer and gastritis [15, 16], but the results are not consistent.
In this study, we therefore intended to investigate the prevalence of gastroesophageal reflux symptoms and to determine whether BMI, waist circumference, waist-to-hip ratio and other factors are associated with the symptoms in the Taizhou Retiree Cohort.
The study cohort and data collection
Taizhou Longitudinal Study phase II (retiree cohort) was started from December of 2007, detailed description of study methods has been published previously , Briefly, all retirees who registered in the Social Insurance Bureau of Hailing (a district of Taizhou city), were invited to undergo a medical examination and their blood samples were collected for testing serum lipid, glucose and other biochemical profile. Information on demographic characteristics, lifestyle, as well as history of major chronic diseases was also collected for each participant. A simplified questionnaire about gastroesophageal reflux symptoms was added since September of 2008 and used till the end of enrollment, August 2009 [18, 19]. The trained interviewers asked the participants whether or not they suffered with heartburn or acid regurgitation in the past 12 months, and if yes, the frequency of the symptoms, and the age the symptoms started. Heartburn and acid regurgitation are the cardinal symptoms of gastroesophageal reflux disease, and the use of questionnaires to assess these symptoms is well validated as a reliable measurement of the true occurrence of reflux [20, 21]. Symptom of “heartburn” was defined as “the burning sensation behind breast bone”, and “acid regurgitation” was defined as “a bitter or sour tasting fluid coming into the throat or chest”. Symptom frequency was reported as: less than once per month, once per month, once per week, 2-3 times per week, 3-4 times per week or daily. We also asked whether the symptoms affected subjects’ daily life including sleep, dietary habits and physical activity. The influences of the of symptoms were reported as negligible, mild (almost can be ignored), moderate (cannot be ignored but can be tolerated), severe (affects normal daily life) and very severe (markedly, affects normal daily life). A summary severity score was then created by taking max value of the influences, and grouping negligible and mild category together. Participants were also asked whether they took medication for their symptoms, such as H2-receptor antagonist (H2Ra) or proton pump inhibitors (PPI).
Body weight, height, waist and hip circumference were measured by trained staff. The waist circumference was measured midway between the caudal point of the costal arch as palpated laterally and the iliac crest. BMI (kg/m2) was calculated as weight (kg) divided by square of height (m). WHR was defined as waist divided by hip circumference. Further, we categorized BMI into three groups, <24.0, 24.0-27.9 and ≥28.0. Overweight was defined as BMI between 24.0 and 27.9, and obesity was defined as BMI ≥28.0 according to the definition proposed by Working Group on Obesity in China .
Abdominal obesity was defined as women with a waist of ≥ 88 cm or man with a waist of ≥ 92 cm (both were upper quarter of waist accordingly). Women with a WHR of ≥ 0.89 or man with a WHR of ≥ 0.95 were also defined as central obesity.
Smoking status was categorized into three groups: ever smoked but quit now, current smokers and never smokers. Participants who reported an average frequency of alcohol intake of over 4 times per month were regarded as regular drinkers; tea drinkers were defined as at least one cup per day.
Participants were also asked to report their history of diseases (with diagnosis from a hospital), including diabetes mellitus, hypertension, cardiovascular and cerebrovascular diseases, tumor, asthma, gastritis, peptic ulcer, hepatitis, tuberculosis and gallstone. Medications taken by participants regularly were also recorded.
We defined GERD cases as ever experiencing symptoms of heartburn and/or regurgitation at least once per week. The control group comprised of those without reported GERD.
Odds ratios (ORs) with 95% confidence intervals (CIs) for the association of potential risk factors with GERD were derived from logistic regression models. All analyses were conducted using SAS version 9.1 (SAS Institute Inc, Cary, NC). Two-sided P values <0.05 were considered statistically significant. The study was approved by the Human Ethics Committee of Fudan University. Written informed consent was obtained from all participants.
From August 2008 to the end of baseline enrollment (Aug 2009), 8867 retirees aged 40 to 93 years completed the questionnaire and physical examination. In the procedure of data cleaning, we deleted 36 records for incomplete age, weight or height. Cohort demographic characteristics are presented in Table 1. Among 8831 participants (with a mean age of 62.5±8.3 years), 64.9% were females and females tended to have lower education level (primary school or lower, female: 60.7% vs. male: 41.4%), and more likely to be blue collar workers (93.9% vs. 79.6%).
Among these 8831 participants, only 158 (1.8%) reported ever having symptom of heartburn, 907 (10.3%) reported ever having symptom of acid regurgitation. Among all these symptomatic subjects, 499 (5.7%) had reflux symptom less than once per month, 281 (3.2%) reported once per month, 72 (0.8%) once per week, 55 (0.6%) several times per week, and 23 (0.3%) daily (Table 1). For the age group 40-49, 50-59, 60-69, 70-79, and 80+, the prevalence rates were 12.8%, 11.6%, 10.2%, 8.8%, and 10.0%, respectively. For women, the prevalence in each age group was: 12.4%, 11.2%, 11.9%, 10.8% and 9.9%. For men, the prevalence was: 14.8%, 14.8%, 8.3%, 7.2% and 10.2%, respectively.
For further analyses, we defined the 150 (1.7%) participants who reported the symptoms (either heartburn or acid regurgitation) at least once a week as GERD cases. Severity and frequency of the symptoms among the 150 cases and the medications they took are presented in Table 2. We deleted 780 participants who reported having the symptom once per month or less to avoid bias from misclassification. The rest of 7901 (89.5%) participants, who reported having neither heartburn nor acid regurgitation, as well as not taking any anti-acids, were considered as controls.
Obesity related factors
Compared with subjects with normal weight, overweight subjects (BMI 24.0-27.9 kg/m2) had a multivariable-adjusted OR of 1.0 (95%CI 0.7-1.4) for developing the symptoms and the corresponding OR was 0.7 (95%CI 0.4-1.2) for obese subjects (BMI ≥28.0 kg/m2) (Table 3). Similarly, waist-to-hip ratio or waist alone did not show any significant association with the symptoms (Table 3).
Lifestyle related factors
Smoking was not associated with any change in the risk of GERD. There was also no significant association between alcohol drinking, tea drinking and the occurrence of reflux symptoms (Table 4).
Past history of diseases
Subjects with self-reported diabetes mellitus were more likely to have report the symptoms, with a multivariable-adjusted OR of 2.2 (95% CI 1.4-3.5). Hypertension was also strongly associated with the development of the symptoms and the corresponding OR was 1.4 (95% CI 1.0-2.1) (Table 5).
Seven hundred and twenty participants reported having chronic gastritis. Compared with those without, subjects with chronic gastritis have an unadjusted OR of 8.5 (95% CI 6.1-11.8) to report GERD symptom. This relation remained stable after further adjustment for all covariates, with an OR of 8.2 (95% CI 5.8-11.5) (Table 5).
Similarly, retirees who had a history of peptic ulcer tended to be more prone to report the reflux symptoms, with an unadjusted OR of 5.1 (95% CI 3.0-8.7), and the association remained strong after multivariable-adjustment, with an OR of 3.3 (95% CI 1.8-6.1) (Table 5).
High serum TG (≥1.81mmol/l) was significantly associated with the presence of GERD (OR: 2.0; 95% CI: 1.3-3.3). This relation remained stable after further adjustment for all covariates, with an OR of 2.0 (95% CI 1.2-3.4) (Table 5).
This population-based study on the epidemiology of GERD surveyed a total of 8867 retired individuals in China. The overall prevalence of GERD in the present study was 1.7% which was lower than that in previous Chinese population-based surveys using a variety of definitions of GERD. A possible explanation for this difference is that the participants in this study were all retirees who did not have much psychological stress. The occurrence and response to treatment of GERD were reported to be associated with stress . In addition, the study subjects in several previous studies were patients who underwent endoscopy in medical centers or those who attended health screening. It is well known that subjects with gastrointestinal symptoms are more likely to go for this kind of examination.
A clear association between GERD and obesity has been found in Western countries [6, 9]. But we did not find an association between obesity and GERD. Previous population-based studies on the association between GERD and BMI in China have also reported inconsistent results [16, 24]. In this study, we assessed the association between GERD and abdominal obesity (indicated by waist circumference and waist-to-hip ratio), but the results did not show any significant association between central obesity and the reflux symptoms. This could potentially be explained by relatively low prevalence of obesity in China.
In the current study, we found an association between diabetes mellitus and GERD. This is consistent with the previous studies performed in Japan  and Korea [25, 26]. A Korean study reported that about 23.1% of the patients with type II diabetes experienced at least weekly typical GERD symptoms . Another study showed that the prevalence of GERD symptoms in diabetes patients was 41% , which was higher than the reported prevalence in the general population. There are several possible mechanisms underlying diabetes-related GERD. Some studies have shown that many gastrointestinal symptoms in diabetes patients are linked to motor dysfunction and that the neuropathy in diabetes patients may play an important role on the development of GERD symptoms. Autonomic nervous disorder in diabetes patients might cause a certain degree of gastric dysmotility which may increase intragastric distension and lead to a higher incidence of transient lower esophageal sphincter relaxation .
Among the individual components of metabolic syndrome, an elevated level of serum TG was a significant predictive factor for the GERD. This result is consistent with previous studies about metabolic syndrome and GERD or erosive esophagitis [12, 27, 28]; however, a Japanese study did not find such an association between elevated serum TG and erosive esophagitis . It has been reported that hypertriglyceridemia is associated with increased insulin resistance  and chronic Helicobacter pylori infections which was suggested to be a protective factor for erosive esophagitis can modify the serum lipid profile [30, 31]. Therefore, elevated serum TG levels may be just an epiphenomenon accompanying other etiologic factors.
Hypertension was found, after adjusting for BMI, to be associated with GERD. In a Japanese study, hypertension and hyperglycaemia were independent risk factors for erosive esophagitis . In a Korean population, the presence of metabolic syndrome and a higher visceral adipose tissue area were suggested as risk factors for esophagitis . Consistent with the above, we found hypertension was a risk factor for symptom-defined GERD, but we did not investigate drug therapy of the participants in the present study. Calcium antagonists used to treat hypertension decrease the lower esophageal sphincter pressure and inhibit muscle contraction in the esophagus itself . In China, calcium antagonists are widely used to treat hypertension, so it is possible that antihypertensive therapy might explain the findings in our study.
The current study supports an association of GERD with a history of peptic ulcer disease and gastritis. A large population-based study on the epidemiology of GERD across five regions in China also reported an association between GERD and peptic ulcer and gastritis . In contrast, a study performed in Finland found a protective effect for gastritis against GERD . However, it is important to distinguish between clinically diagnosed gastritis and the patient-reported history of gastritis which was used in the current study. In China, “gastritis” generally indicates upper gastrointestinal discomfort and a diagnosis is unlikely to be based on endoscopic examination biopsy or serum pepsinogen measurement. The major limitation of our study is that the medical history of participants was self-reported is the biggest limitation of our study, but it should be noted that it is a standard practice in China for patients to keep their own medical records which, in some extent, may reduce the impact of this limitation.
This study showed the prevalence of GERD in this retiree cohort is lower than that in Western populations, and its occurrence is independent of obesity or abdominal obesity. However, elevated level of serum TG, a medical history of hypertension, diabetes, peptic ulcer disease and gastritis are associated with an increased risk of developing GERD in this population. Further studies are needed to more fully elucidate potential mechanisms underlying these relationships.
Dent J, El-Serag HB, Wallander MA, Johansson S: Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005, 54: 710-717. 10.1136/gut.2004.051821.
Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK: Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol. 2000, 15: 230-238. 10.1046/j.1440-1746.2000.02148.x.
Lim LG, Ho KY: Gastroesophageal reflux disease at the turn of millennium. World J Gastroenterol. 2003, 9: 2135-2136.
Goh KL: Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004, 19 (Suppl 3): S22-S25.
Fujimoto K: Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004, 20 (Suppl 8): 5-8.
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J: Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003, 290: 66-72. 10.1001/jama.290.1.66.
Hampel H, Abraham NS, El-Serag HB: Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005, 143: 199-211.
Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA: Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006, 354: 2340-2348. 10.1056/NEJMoa054391.
Corley DA, Kubo A, Zhao W: Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007, 56: 756-762. 10.1136/gut.2006.109413.
Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ: Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007, 132: 883-889. 10.1053/j.gastro.2006.12.032.
Sise A, Friedenberg FK: A comprehensive review of gastroesophageal reflux disease and obesity. Obes Rev. 2008, 9: 194-203. 10.1111/j.1467-789X.2007.00459.x.
Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH: The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009, 58: 174-181. 10.1136/gut.2008.162305.
Moki F, Kusano M, Mizuide M, Shimoyama Y, Kawamura O, Takagi H, Imai T, Mori M: Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther. 2007, 26: 1069-1075. 10.1111/j.1365-2036.2007.03454.x.
Wang X, Pitchumoni CS, Chandrarana K, Shah N: Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008, 14: 709-712. 10.3748/wjg.14.709.
Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M: Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion. 2000, 61: 6-13. 10.1159/000007730.
He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, Yin P, Kang X, Fang J, Hao Y, et al: A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the systematic investigation of gastrointestinal diseases in China. BMC Gastroenterol. 2010, 10: 94-10.1186/1471-230X-10-94.
Wang X, Lu M, Qian J, Yang Y, Li S, Lu D, Yu S, Meng W, Ye W, Jin L: Rationales, design and recruitment of the Taizhou longitudinal study. BMC Public Health. 2009, 9: 223-10.1186/1471-2458-9-223.
Chinese Gastroesophageal Reflux Disease Study Group: The value of reflux diagnostic questionnaires in the diagnosis of gastroesophageal reflux disease. Chin J Dig. 2003, 23: 651-654. in Chinese
Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P: Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001, 96: 52-57. 10.1111/j.1572-0241.2001.03451.x.
Klauser AG, Schindlbeck NE, Muller-Lissner SA: Symptoms in gastro-oesophageal reflux disease. Lancet. 1990, 335: 205-208. 10.1016/0140-6736(90)90287-F.
Revicki DA, Wood M, Wiklund I, Crawley J: Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998, 7: 75-83.
Zhou B: Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002, 23: 5-10.
Mizyed I, Fass SS, Fass R: Review article: gastro-oesophageal reflux disease and psychological comorbidity. Aliment Pharmacol Ther. 2009, 29: 351-358. 10.1111/j.1365-2036.2008.03883.x.
Wang JH, Luo JY, Dong L, Gong J, Tong M: Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol. 2004, 10: 1647-1651.
Lee SD, Keum B, Chun HJ, Bak YT: Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. J Neurogastroenterol Motil. 2011, 17: 274-278. 10.5056/jnm.2011.17.3.274.
Song HJ, Shim KN, Yoon SJ, Kim SE, Oh HJ, Ryu KH, Ha CY, Yeom HJ, Song JH, Jung SA, et al: The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome. J Korean Med Sci. 2009, 24: 197-202. 10.3346/jkms.2009.24.2.197.
Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, Song IS: Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case–control study of 7078 Koreans undergoing health check-ups. Gut. 2008, 57: 1360-1365. 10.1136/gut.2007.147090.
Cholongitas E, Pipili C, Dasenaki M: Gastro-oesophageal reflux disease and irritable bowel syndrome significantly associated with metabolic syndrome. Scand J Gastroenterol. 2008, 43: 1405-1406. 10.1080/00365520802308029.
Moro E, Gallina P, Pais M, Cazzolato G, Alessandrini P, Bittolo-Bon G: Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes. Metabolism. 2003, 52: 616-619. 10.1053/meta.2003.50102.
Tsukada K, Katoh H, Miyazaki T, Fukuchi M, Kuwano H, Kimura H, Fukai Y, Inose T, Motojima T, Toda N, et al: Factors associated with the development of reflux esophagitis after helicobacter pylori eradication. Dig Dis Sci. 2006, 51: 539-542. 10.1007/s10620-006-3167-2.
Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P: Association of helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999, 142: 207-210. 10.1016/S0021-9150(98)00194-4.
Hongo M, Traube M, McAllister RG, McCallum RW: Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology. 1984, 86: 8-12.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/12/161/prepub
This work was supported by a grant from NSFC (81072358), a grant from SDSTC (2012GSF11857) and a grant from JSSTSP (BE2011763). The authors’ work was independent of the funding providers.
The authors declare that they have no competing interests.
ML, LJ, WY, XW and YY made substantial contributions to the conception and design of the study. TC and ML performed the statistical analysis and drafted the manuscript. WY, ML and TC have been involved in revising the manuscript critically for important intellectual content. JZ participated in data collection. All authors read and approved the final manuscript.
About this article
Cite this article
Chen, T., Lu, M., Wang, X. et al. Prevalence and risk factors of gastroesophageal reflux symptoms in a Chinese retiree cohort. BMC Gastroenterol 12, 161 (2012). https://doi.org/10.1186/1471-230X-12-161
- Gastroesophageal reflux symptoms
- Body mass index
- Abdominal obesity
- Retired population